No Data
No Data
Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock?
Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024
EL MONTE, Calif.--(BUSINESS WIRE)--Jul. 11, 2024--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business
With 50% Ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) Boasts of Strong Institutional Backing
Press Release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
PRESS RELEASE - 10/06/2024, 07:00 CEST Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing Mechelen, Belgium 10 June 2024 – Biocartis NV (the 'Company' or
What Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Share Price Doing?
Fulgent Data at ASCO 2024 Highlights Antitumor Activity From Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer
EL MONTE, Calif.--(BUSINESS WIRE)--Jun. 3, 2024-- Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: FLGT) and a leading nanobiotechnology company specializing in innovative cancer therap
No Data
Silverbat : Buy at dips and hold for 192